Developer docs
API playgroundTry for free, no card

Search company profiles

SiPhox Health

Full company profile

uuid0000fr9

Namestring
SiPhox Health
Legal namestring
SiPhox, Inc.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

SiPhox Health is a Burlington, Massachusetts-based health diagnostics company founded in 2020 by two MIT researchers that builds at-home blood biomarker testing infrastructure using a proprietary silicon photonics platform that integrates photonics, electronics, and microfluidics on a chip. Its core consumer offering, EasyDraw, is a painless upper-arm blood collection kit that ships to members, with samples processed at CLIA- and CAP-accredited labs and results delivered (typically within 7–10 days) through an AI-powered dashboard featuring the Sai conversational assistant, BioAge calculation, optimal-range analysis, and personalized supplement and lifestyle action plans.

The company operates a modular product architecture: members subscribe to flexible-cadence testing (monthly, quarterly, or every 6 months) and select from purpose-built panels including Longevity Essentials, Heart & Metabolic, Hormone Focus, Thyroid Focus, GLP Optimization (for patients on GLP-1 therapies), and the comprehensive Ultimate 360 (up to 59 biomarkers). An investigational in-home device, SiPhox Home, extends the same silicon photonics approach to deliver lab-quality results in 60 minutes and is positioned for FDA-cleared consumer rollout, targeting cardio, metabolic, inflammation, women's health, and oncology screening applications.

Commercially, SiPhox combines a direct-to-consumer e-commerce channel through siphoxhealth.com with a B2B white-label and API partner program serving longevity clinics, wellness brands, wellness retreats, employers, coaches, and research/pharma organizations. Strategic distribution has been amplified by a 2026 Samsung partnership integrating SiPhox into Samsung Health and SmartThings, and the company has raised approximately $32.8 million across seed, Series A, and follow-on rounds led by Intel Capital with participation from Khosla Ventures, Y Combinator, and a broader syndicate.

Short descriptiontext

SiPhox Health is a Burlington, MA-based diagnostics company (founded 2020 by MIT researchers) that operates an at-home blood biomarker testing platform built on proprietary silicon photonics and the painless EasyDraw collection kit, serving health-conscious consumers, longevity clinics, employers, and research organizations through DTC subscriptions and a white-label API.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBurlington, United States
HQ citystring
Burlington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home blood testing, biomarker diagnostics, silicon photonics, health monitoring platform, preventive diagnostics
Industry1 code
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
At-home blood diagnostic testing
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Membership
TypeSubscription Recurring
Description

Recurring subscription model with membership fee covering testing panels, dashboard access, AI insights, and member benefits. Flexible testing cadence - users test monthly, quarterly, or every 6 months. Membership starts at $99-$124 per test with shipping. Cancel anytime.

siphoxhealth.com
2Premium Panel Upgrades
TypeSubscription Recurring
Description

Additional fees for enhanced biomarker panels: GLP Monitoring Panel (+$75), Wellness+ (+$40), Wellness & Hormone (+$75), Wellness & Thyroid (+$75), Ultimate 360 (+$125). Upsell opportunity within subscription.

siphoxhealth.com
3White-Label Partnership Licensing
TypeLicensing Royalties
Description

B2B licensing of testing infrastructure, dashboard, and API to longevity clinics, wellness brands, employers, and healthcare providers. Partners can co-brand or integrate via API for custom experiences.

siphoxhealth.com
4Partner Integrations and Add-ons
TypeAffiliate Referral
Description

Commission-based partnerships with Prenuvo (Whole Body MRI), health coaching sessions, gut microbiome testing, and allergy panels offered as exclusive member benefits. Company earns referral fees or negotiated rates.

siphoxhealth.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details7 tiers
1Longevity Essentials - Core biomarker panel (24-29 biomarkers)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

$124 per test (introductory offer $99 + shipping). Included with membership. Tests cardiovascular, metabolic, hormonal, and nutritional biomarkers.

siphoxhealth.com
2Heart & Metabolic Panel - 26 biomarkers focused on cardiovascular health
ModelSubscriptionBilling cadencePay-as-you-go
Notes

26 biomarkers per test (upgradeable up to 59). Heart health, inflammation, metabolic health, kidney, liver, nutritional markers.

siphoxhealth.com
3Hormone Focus Panel - 14 biomarkers for hormonal health
ModelSubscriptionBilling cadencePay-as-you-go
Notes

14 biomarkers per test (upgradeable up to 59). Tracks testosterone, estradiol, FSH, LH, DHEA-S, SHBG, prolactin, progesterone.

siphoxhealth.com
4Thyroid Focus Panel - 21 biomarkers for thyroid assessment
ModelSubscriptionBilling cadencePay-as-you-go
Notes

21 biomarkers per test (upgradeable up to 59). Free T3, Free T4, TPOAb, TgAb, TSH ratios.

siphoxhealth.com
5GLP Monitoring Panel - 40+ biomarkers for GLP therapy tracking
ModelSubscriptionBilling cadencePay-as-you-go
Notes

$199 per test + shipping. 40+ direct and calculated lab markers across metabolism, lipids, liver, kidney, thyroid, hormones, nutrition, inflammation. Plus body-composition scanning and symptom check-ins.

siphoxhealth.com
6Ultimate 360 - Comprehensive panel with 59 biomarkers
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Membership + $125 upgrade. Most comprehensive panel measuring key biomarkers across cardiovascular, metabolic, hormonal, thyroid, liver, kidney, inflammation, and nutritional health.

siphoxhealth.com
7Add-on Panels (Wellness+, Hormone+, Metabolic+, Thyroid+)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Wellness+ (+$40), Wellness & Hormone (+$75), Wellness & Metabolic (+$75), Wellness & Thyroid (+$75). Add hormone, metabolic, or thyroid biomarkers to base panels.

siphoxhealth.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 8 records shown
1EasyDraw
Description

Painless upper-arm blood collection device for at-home biomarker testing

siphoxhealth.com
+7 more records
Core offering1 text field

SiPhox Health operates an at-home blood biomarker testing service in which members collect a blood sample via the painless EasyDraw upper-arm device, mail it to CLIA/CAP-accredited labs, and receive results in 7-10 days through an AI-powered dashboard (Sai assistant) with personalized action plans. The offering is sold primarily as a consumer membership with flexible testing cadence ($99-$199 per test) and is also licensed as a white-label platform/API to longevity clinics, wellness brands, employers, and research organizations. An investigational SiPhox Home silicon photonics device is in development to deliver lab-quality results in 60 minutes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 50,000+ individuals using the platform for health tracking
+4 more records
Product overview1 text field

SiPhox Health operates as a platform-plus-modules architecture built around its EasyDraw at-home blood testing platform and the upcoming SiPhox Home silicon photonics device. The core offering is a membership-based service ($99-199/month) providing painless at-home biomarker testing with AI-powered insights. Members choose from specialized program panels: Longevity Essentials (included), Thyroid Focus, Hormone Focus, Heart & Metabolic, GLP Optimization (for medication monitoring), and Ultimate 360 (comprehensive 59-biomarker panel). All results are delivered through a unified dashboard featuring the Sai AI assistant for personalized recommendations and supplement optimization. The company also offers a Partner Platform enabling white-label or API integration for healthcare providers, wellness brands, and employers.

Product and service5 records
1EasyDraw At-Home Blood Testing Platform
CategoryCore consumer diagnostics service
2Ultimate 360 Program
CategoryComprehensive biomarker panel program
3GLP Optimization Panel
CategorySpecialized biomarker panel program
4SiPhox Home Device
CategoryConsumer diagnostic hardware device
5Partner Platform & White-Label Testing Solutions
CategoryB2B platform / white-label licensing
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-19
Description

Partnership announced at VivaTech 2026 in Paris. SiPhox Health is one of three health startups (alongside Generation Lab and Xealth) in Samsung's connected care vision. Integrates with Samsung Health (77M MAU) and SmartThings (460M devices) ecosystem to enable hospital-grade blood testing at home. Samsung opened Samsung Health SDK Suite to developers.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-19
Description

Health startup partner in Samsung's connected care ecosystem announcement at VivaTech 2026. Co-showcased with SiPhox as part of Samsung's preventive health platform vision.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-19
Description

Health startup partner in Samsung's connected care ecosystem announcement at VivaTech 2026. Panelists discussed integration with Samsung's ecosystem for services ranging from biological age tracking to hospital-grade blood testing.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Exclusive member-only partnership offering Prenuvo Whole Body MRI scans at discounted prices to SiPhox members. Partnership provides additional health insights (full-body MRI) that complement biomarker data.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Independent healthcare provider group providing telehealth clinical services for SiPhox Heart and Metabolic Program members seeking medication management. Clinicians review questionnaire and test results, establish patient-physician relationship.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partner brand shown in SiPhox Health partner logo section. Nature of partnership (reseller, referral, integration) not fully specified.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partner brand shown in SiPhox Health partner logo section. Wellness brand potentially integrating or reselling SiPhox testing services.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partner brand shown in SiPhox Health partner logo section. Nature of partnership (reseller, referral, integration) not fully specified.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

At-home microbiome and blood transcriptomics testing with personalized nutrition recommendations. Comparable at-home collection + AI-powered wellness insights motion.

TypeDirect peer
Description

At-home collection-based health testing brand offering panels for hormones, thyroid, metabolism and more with physician-reviewed results. Competes directly in D2C lab testing with overlapping panel structures.

3Function Health
TypeDirect peer
Description

Direct D2C competitor offering comprehensive at-home blood biomarker testing (100+ markers) with physician review and personalized action plans. Closest comparable in membership-based preventive blood testing model.

TypeDirect peer
Description

Personalized health analytics platform offering at-home blood testing with biomarker analysis and science-based recommendations for nutrition, exercise, and supplementation. Directly competes in the longevity/biohacker preventive testing niche.

TypeEmerging player
Description

Whole-body MRI preventive scanning service that already has an exclusive member-discount partnership with SiPhox. Overlaps on preventive-health-conscious consumer target market.

TypeDirect peer
Description

At-home health testing company with finger-prick/venous sample collection connected to physician-reviewed results and prescription services. Comparable D2C diagnostics model.

TypeBroad incumbent
Description

Major clinical laboratory network with at-home and direct-to-consumer testing services (e.g., Labcorp OnDemand). Establishes the standard against which SiPhox validates accuracy (per their comparison claims).

TypeDirect peer
Description

Supplement + at-home testing company with health testing kits combined with personalized supplement recommendations. Direct overlap in the "test-then-act" wellness consumer motion.

TypeBroad incumbent
Description

Largest clinical laboratory services company in the US, providing blood testing through physician orders and direct consumer offerings (e.g., Quest's Blueprint). Broad incumbent competing for the same biomarker testing demand.

TypeEmerging player
Description

Continuous glucose monitoring-driven metabolic health platform with overlapping biohacker/longevity consumer base. Adjacent rather than direct overlap, with CGM vs blood biomarker testing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SiPhox Health

At-home blood diagnostic testingsiphoxhealth.com

SiPhox Health is a Burlington, MA-based diagnostics company (founded 2020 by MIT researchers) that operates an at-home blood biomarker testing platform built on proprietary silicon photonics and the painless EasyDraw collection kit, serving health-conscious consumers, longevity clinics, employers, and research organizations through DTC subscriptions and a white-label API.

What SiPhox Health does

SiPhox Health is a Burlington, Massachusetts-based health diagnostics company founded in 2020 by two MIT researchers that builds at-home blood biomarker testing infrastructure using a proprietary silicon photonics platform that integrates photonics, electronics, and microfluidics on a chip. Its core consumer offering, EasyDraw, is a painless upper-arm blood collection kit that ships to members, with samples processed at CLIA- and CAP-accredited labs and results delivered (typically within 7–10 days) through an AI-powered dashboard featuring the Sai conversational assistant, BioAge calculation, optimal-range analysis, and personalized supplement and lifestyle action plans.

The company operates a modular product architecture: members subscribe to flexible-cadence testing (monthly, quarterly, or every 6 months) and select from purpose-built panels including Longevity Essentials, Heart & Metabolic, Hormone Focus, Thyroid Focus, GLP Optimization (for patients on GLP-1 therapies), and the comprehensive Ultimate 360 (up to 59 biomarkers). An investigational in-home device, SiPhox Home, extends the same silicon photonics approach to deliver lab-quality results in 60 minutes and is positioned for FDA-cleared consumer rollout, targeting cardio, metabolic, inflammation, women's health, and oncology screening applications.

Commercially, SiPhox combines a direct-to-consumer e-commerce channel through siphoxhealth.com with a B2B white-label and API partner program serving longevity clinics, wellness brands, wellness retreats, employers, coaches, and research/pharma organizations. Strategic distribution has been amplified by a 2026 Samsung partnership integrating SiPhox into Samsung Health and SmartThings, and the company has raised approximately $32.8 million across seed, Series A, and follow-on rounds led by Intel Capital with participation from Khosla Ventures, Y Combinator, and a broader syndicate.

SiPhox Health firmographics

Firmographics
Name
SiPhox Health
Legal name
SiPhox, Inc.
Website
https://siphoxhealth.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
SiPhox Health is a Burlington, MA-based diagnostics company (founded 2020 by MIT researchers) that operates an at-home blood biomarker testing platform built on proprietary silicon photonics and the painless EasyDraw collection kit, serving health-conscious consumers, longevity clinics, employers, and research organizations through DTC subscriptions and a white-label API.
Ownership category
akta.pro rank

SiPhox Health industry classification

Industry
Product category
At-home blood diagnostic testing
NAICS
Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • At-home blood testing
  • Biomarker diagnostics
  • Silicon photonics
  • Health monitoring platform
  • Preventive diagnostics

Where SiPhox Health is headquartered

Location

Headquarters

HQ city
Burlington
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SiPhox Health business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Subscription Membership: Recurring subscription model with membership fee covering testing panels, dashboard access, AI insights, and member benefits. Flexible testing cadence - users test monthly, quarterly, or every 6 months. Membership starts at $99-$124 per test with shipping. Cancel anytime.
  2. Premium Panel Upgrades: Additional fees for enhanced biomarker panels: GLP Monitoring Panel (+$75), Wellness+ (+$40), Wellness & Hormone (+$75), Wellness & Thyroid (+$75), Ultimate 360 (+$125). Upsell opportunity within subscription.
  3. White-Label Partnership Licensing: B2B licensing of testing infrastructure, dashboard, and API to longevity clinics, wellness brands, employers, and healthcare providers. Partners can co-brand or integrate via API for custom experiences.
  4. Partner Integrations and Add-ons: Commission-based partnerships with Prenuvo (Whole Body MRI), health coaching sessions, gut microbiome testing, and allergy panels offered as exclusive member benefits. Company earns referral fees or negotiated rates.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goLongevity Essentials - Core biomarker panel (24-29 biomarkers)
SubscriptionPay-as-you-goHeart & Metabolic Panel - 26 biomarkers focused on cardiovascular health
SubscriptionPay-as-you-goHormone Focus Panel - 14 biomarkers for hormonal health
SubscriptionPay-as-you-goThyroid Focus Panel - 21 biomarkers for thyroid assessment
SubscriptionPay-as-you-goGLP Monitoring Panel - 40+ biomarkers for GLP therapy tracking
SubscriptionPay-as-you-goUltimate 360 - Comprehensive panel with 59 biomarkers
SubscriptionPay-as-you-goAdd-on Panels (Wellness+, Hormone+, Metabolic+, Thyroid+)

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

SiPhox Health product offering

Product offering

Core offering

SiPhox Health operates an at-home blood biomarker testing service in which members collect a blood sample via the painless EasyDraw upper-arm device, mail it to CLIA/CAP-accredited labs, and receive results in 7-10 days through an AI-powered dashboard (Sai assistant) with personalized action plans. The offering is sold primarily as a consumer membership with flexible testing cadence ($99-$199 per test) and is also licensed as a white-label platform/API to longevity clinics, wellness brands, employers, and research organizations. An investigational SiPhox Home silicon photonics device is in development to deliver lab-quality results in 60 minutes.

Product overview

SiPhox Health operates as a platform-plus-modules architecture built around its EasyDraw at-home blood testing platform and the upcoming SiPhox Home silicon photonics device. The core offering is a membership-based service ($99-199/month) providing painless at-home biomarker testing with AI-powered insights. Members choose from specialized program panels: Longevity Essentials (included), Thyroid Focus, Hormone Focus, Heart & Metabolic, GLP Optimization (for medication monitoring), and Ultimate 360 (comprehensive 59-biomarker panel). All results are delivered through a unified dashboard featuring the Sai AI assistant for personalized recommendations and supplement optimization. The company also offers a Partner Platform enabling white-label or API integration for healthcare providers, wellness brands, and employers.

Differentiator

Problem solved

Functional benefit

Brands

  • EasyDraw: Painless upper-arm blood collection device for at-home biomarker testing
  • SiPhox Home
  • Ultimate 360
  • Longevity Essentials
  • Heart & Metabolic
  • Hormone Focus
  • Thyroid Focus
  • GLP Optimization

Products and services

  • EasyDraw At-Home Blood Testing Platform
  • Ultimate 360 Program
  • GLP Optimization Panel
  • SiPhox Home Device
  • Partner Platform & White-Label Testing Solutions

Quantifiable outcome

  • 50,000+ individuals using the platform for health tracking
  • +4 more outcomes

Companies that use SiPhox Health

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

SiPhox Health technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature5 records

SiPhox Health partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, minor and core.

  • SamsungflagshipStrategic or Co-development Partner · 19 June 2026Partnership announced at VivaTech 2026 in Paris. SiPhox Health is one of three health startups (alongside Generation Lab and Xealth) in Samsung's connected care vision. Integrates with Samsung Health (77M MAU) and SmartThings (460M devices) ecosystem to enable hospital-grade blood testing at home. Samsung opened Samsung Health SDK Suite to developers.
  • Generation LabminorStrategic or Co-development Partner · 19 June 2026Health startup partner in Samsung's connected care ecosystem announcement at VivaTech 2026. Co-showcased with SiPhox as part of Samsung's preventive health platform vision.
  • XealthminorStrategic or Co-development Partner · 19 June 2026Health startup partner in Samsung's connected care ecosystem announcement at VivaTech 2026. Panelists discussed integration with Samsung's ecosystem for services ranging from biological age tracking to hospital-grade blood testing.
  • PrenuvocoreGTM or Marketing PartnerExclusive member-only partnership offering Prenuvo Whole Body MRI scans at discounted prices to SiPhox members. Partnership provides additional health insights (full-body MRI) that complement biomarker data.
  • Beluga Health P.A. of FloridacoreImplementation/ SI/ Consulting PartnerIndependent healthcare provider group providing telehealth clinical services for SiPhox Heart and Metabolic Program members seeking medication management. Clinicians review questionnaire and test results, establish patient-physician relationship.
  • Million markerminorChannel Partner/ Reseller/ DistributorPartner brand shown in SiPhox Health partner logo section. Nature of partnership (reseller, referral, integration) not fully specified.
  • MiraminorChannel Partner/ Reseller/ DistributorPartner brand shown in SiPhox Health partner logo section. Wellness brand potentially integrating or reselling SiPhox testing services.
  • PeopleScienceminorChannel Partner/ Reseller/ DistributorPartner brand shown in SiPhox Health partner logo section. Nature of partnership (reseller, referral, integration) not fully specified.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

SiPhox Health competitors and assessment

Company assessment

Emerging players

  • Viome: At-home microbiome and blood transcriptomics testing with personalized nutrition recommendations. Comparable at-home collection + AI-powered wellness insights motion.
  • Prenuvo: Whole-body MRI preventive scanning service that already has an exclusive member-discount partnership with SiPhox. Overlaps on preventive-health-conscious consumer target market.
  • Levels Health: Continuous glucose monitoring-driven metabolic health platform with overlapping biohacker/longevity consumer base. Adjacent rather than direct overlap, with CGM vs blood biomarker testing.

Direct peers

  • Everlywell: At-home collection-based health testing brand offering panels for hormones, thyroid, metabolism and more with physician-reviewed results. Competes directly in D2C lab testing with overlapping panel structures.
  • Function Health: Direct D2C competitor offering comprehensive at-home blood biomarker testing (100+ markers) with physician review and personalized action plans. Closest comparable in membership-based preventive blood testing model.
  • InsideTracker: Personalized health analytics platform offering at-home blood testing with biomarker analysis and science-based recommendations for nutrition, exercise, and supplementation. Directly competes in the longevity/biohacker preventive testing niche.
  • LetsGetChecked: At-home health testing company with finger-prick/venous sample collection connected to physician-reviewed results and prescription services. Comparable D2C diagnostics model.
  • Thorne: Supplement + at-home testing company with health testing kits combined with personalized supplement recommendations. Direct overlap in the "test-then-act" wellness consumer motion.

Broad incumbents

  • Labcorp: Major clinical laboratory network with at-home and direct-to-consumer testing services (e.g., Labcorp OnDemand). Establishes the standard against which SiPhox validates accuracy (per their comparison claims).
  • Quest Diagnostics: Largest clinical laboratory services company in the US, providing blood testing through physician orders and direct consumer offerings (e.g., Quest's Blueprint). Broad incumbent competing for the same biomarker testing demand.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

SiPhox Health social profiles

Digital presence

SiPhox Health compliance and trust

Trust signal

Compliance4 records

SiPhox Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SiPhox Health leadership team

Management profile

Number of profiles

Profiles9 records

SiPhox Health funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SiPhox Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SiPhox Health

What does SiPhox Health do?

SiPhox Health operates an at-home blood biomarker testing service in which members collect a blood sample via the painless EasyDraw upper-arm device, mail it to CLIA/CAP-accredited labs, and receive results in 7-10 days through an AI-powered dashboard (Sai assistant) with personalized action plans. The offering is sold primarily as a consumer membership with flexible testing cadence ($99-$199 per test) and is also licensed as a white-label platform/API to longevity clinics, wellness brands, employers, and research organizations. An investigational SiPhox Home silicon photonics device is in development to deliver lab-quality results in 60 minutes.

Is SiPhox Health a public or private company?

SiPhox Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was SiPhox Health founded?

SiPhox Health was founded in 2020. It employs 51 to 100 people.

Where is SiPhox Health based?

SiPhox Health is headquartered in Burlington, United States, in the North America region.

How does SiPhox Health make money?

Four revenue lines are on record. Subscription Membership is the primary driver. The others are premium Panel Upgrades, white-Label Partnership Licensing and partner Integrations and Add-ons.

Who are SiPhox Health's main competitors?

Emerging players on record are Viome, Prenuvo and Levels Health. Direct peers are Everlywell, Function Health, InsideTracker, LetsGetChecked and Thorne. Broad incumbents are Labcorp and Quest Diagnostics.

Does SiPhox Health have an API?

Yes. SiPhox offers an API for partners to integrate blood test results into their own platforms. Partners can choose between a co-branded dashboard or seamless API integration. The API provides customizable software for reviewing and displaying test results, enabling structured and actionable health data to be delivered through partner platforms.

What industry is SiPhox Health in?

SiPhox Health's product category is At-home blood diagnostic testing. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care. Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Samsung Mobile PressSamsung Highlights Open Ecosystem To Accelerate Connected Care for Daily Wellness at VivaTech 2026Samsung Electronics highlighted its vision for connected care through an open collaboration ecosystem during a panel discussion at VivaTech 2026 in Paris. The company showcased partnerships with Xealth, Generation Lab, and SiPhox Health to integrate diagnostic and wellness services into its SmartThings and Samsung Health platforms.TechbuzzSamsung Unveils Connected Care Vision With Health StartupsSamsung unveiled its connected health care vision at VivaTech 2026 in Paris, announcing partnerships with health startups SiPhox Health, Generation Lab, and Xealth to transform its device ecosystem into a preventive health platform. The company disclosed that Samsung Health has 77 million monthly active users and SmartThings connects 460 million devices globally, offering startups immediate distribution scale. Samsung also opened its Samsung Health SDK Suite to developers and emphasized its Knox security infrastructure as the trust layer for moving sensitive health data across its ecosystem of wearables, appliances, and TVs.Samsung Global NewsroomSamsung Highlights Open Ecosystem To Accelerate Connected Care for Daily Wellness at VivaTech 2026Samsung Electronics presented its connected care vision at VivaTech 2026 in Paris, highlighting how its open collaboration ecosystem spanning devices from smartphones to home appliances can drive proactive daily wellness. The company showcased its scale with Samsung Health supporting 77 million monthly active users and SmartThings connecting 460 million users. Panelists from partner companies Xealth, Generation Lab, and SiPhox Health discussed how integration with Samsung's ecosystem enables services ranging from biological age tracking to hospital-grade blood testing at home.MenlotimesY Combinator Launches of the WeekY Combinator's weekly round-up features six new companies: Atrisa, SiPhox Health, Zenbu, Wato, Miso Labs, and Hexa. Each company is described by its founders and its product focus, ranging from AI agents for circuit design to voice foundation models.GoogleWhy are people turning to at-home blood testing? Meet SiPhox HealthA promotional article describes SiPhox Health, an at-home blood testing platform that lets users test up to 60 biomarkers without a lab visit, using a needle-free EasyDraw collection device. Pricing starts at $99 for new members, with CLIA-certified lab processing and results delivered via a personalized dashboard.TechBullionDuped by Rami Abrams of Burlington-based Health Tech Startup SiPhox HealthA Reddit marketing expert with Top Rated Plus status on Upwork claims they were defrauded by Rami Abrams, Head of Growth at SiPhox Health, a Burlington-based health diagnostics startup founded by MIT researchers in 2020. The freelancer alleges that after delivering exactly the agreed-upon work for a marketing project, Abrams disputed the work, refused to pay, and left a malicious negative review to damage the freelancer's reputation and livelihood. The article frames this as a cautionary example of common freelancer scams and warns that such dishonest conduct poses reputational, financial, and legal risks to companies in the highly regulated medical industry.BioSpaceSiPhox Health Introduces a Smarter Way of Health Tracking From HomeSiPhox Health, a health technology company founded by two MIT scientists based in Burlington, Massachusetts, has introduced an at-home blood testing and health tracking platform that uses silicon photonic chips to make diagnostics more efficient. The platform, called EasyDraw, offers needle-free blood sample collection and tracks over 50 biomarkers, with results processed by CLIA/CAP accredited labs. The company also provides AI-powered personalized health insights, supplement recommendations, and integrates with wearable devices and third-party lab results into a unified dashboard.SiphoxhealthComprehensive Health Testing & Biomarker AnalysisSiPhox Health is advancing health solutions by leveraging expert input from various healthcare professionals. The team includes specialists in cardiology, metabolic health, and clinical operations, focusing on developing and launching innovative health programs, particularly addressing health disparities.National Center for Biotechnology InformationRecent Advances in Flexible Materials for Wearable Optical BiosensorsThis review article analyzes recent advancements in flexible materials, such as polymers, nanomaterials, and hydrogels, used to enhance wearable optical biosensors for health monitoring and disease prevention. It highlights key companies like Rockley Photonics and Siphox Health that are driving the commercialization of these technologies for continuous physiological tracking.